Heron Therapeutics (HRTX) Tops Q1 EPS by 3c

Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $38.9 million versus the consensus estimate of $34.25 million.

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Active options: NVDA TSLA SPCX AAPL AMZN MU INTC NFLX MSFT PLTR
• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ